ULIPRISTALACETAT-TABLETTEN

European patent · EP2365800 · Deleted

Register entry

Publication number
EP2365800
Application number
EP09764855
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 8, 2009
Published
Sep 21, 2011
Granted
Jul 20, 2016
Deleted
Jan 25, 2023
Reason
Revoked in opposition
IPC classes
A61K 9/20 (2006.01)
A61K 31/56 (2006.01)
Priority
US 329865 08.12.2008
PCT application
PCT/EP2009/066652 08.12.2009
PCT publication
WO2010/066749 17.06.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 25, 2023

    Change

    Published in Swissreg on 25.01.2023

  2. Jul 21, 2021

    Deleted, fee unpaid

    Published in Swissreg on 21.07.2021

  3. Jul 20, 2016

    Granted

    Published in Swissreg on 20.07.2016

Parties

Holder

Laboratoire HRA PHARMA

Laboratoire HRA Pharma

15, rue Béranger, 75003 Paris, FR

Inventor

GAINER, Erin

F-75019 Paris, FR

GUILLARD, Hélène

F-75011 Paris, FR

GICQUEL, Denis

F-78630 Orgeval, FR

HENRION, Marianne

F-75005 Paris, FR

GNAKAMENE, Céline

F-75014 Paris, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.